Science Market Update

UCLA receives $4.2M from NIH to Study Placental Development

Posted by Robert Larkin on Tue, Nov 24, 2015

During pregnancy, much of a fetus’ development is contingent on the condition and function of the placenta. It is responsible for the transmission of substances from mother to child that are critical to early development, including blood, oxygen and nutrients, without which the fetus could not exist. Sometimes, however, environmental effects can cause deficiencies in the placenta, which can lead to harmful side effects such as preterm birth or even death.

Read More

Tags: CA, University of California Los Angeles, Medical Research, California, Los Angeles, Development, UCLA, Biotechnology Vendor Showcase, NIH funding, NIH award, Southwest Region, 2016, best science tradeshows, pollution, pregnancy

UCLA Researchers I.D. Tumor-Fueling Mechanism

Posted by Robert Larkin on Tue, Aug 04, 2015

Like any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer

UCLA Studies Radiation's Prevalence in Prostate Cancer Treatments

Posted by Robert Larkin on Tue, Mar 10, 2015

While not necessarily always the best course of treatment, the majority of men with prostate cancer will go with radiation treatment when confronted with options for treating the potentially deadly disease. Unlike other options, including surgery and chemotherapy, radiation treatment is a relatively “outpatient” procedure - with no anesthetic needed, targeted effectiveness, and relatively few short term side effects.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, LA, 2015, LAVS, UCLA, Biotechnology Vendor Showcase Event, Prostate cancer

UCLA's David Geffen School of Medicine receives $50M

Posted by Robert Larkin on Mon, Feb 09, 2015

The sciences of medical care, medical teaching and bioresearch at University of California, Los Angeles have received a boost in the form of an unrestricted gift of $50 million. Given to the David Geffen School of Medicine at UCLA from the estate of Irma and Norman Switzer, the gift was announced Nov. 12 at a gathering of faculty, staff members, the school’s board of visitors and friends of the Switzer family.  

Read More

Tags: CA, cardiovascular research, California, Los Angeles, 2015, LAVS, UCLA, Research Funding, Biotechnology Vendor Showcase Event

UCLA Bioresearch Team Captures Cancer Cells in Bloodstream

Posted by Sam Asher on Thu, Jan 15, 2015

Sometimes eradicating the tumor is only a partial defeat for cancer. Tumors release cancerous cells into the bloodstream that can form new tumors. A team at the University of California, Los Angeles has devised a clever strategy for detecting and collecting these errant cells so they can be stopped and studied to prevent further harm.

Read More

Tags: CA, University of California Los Angeles, 2015, UCLA

Largest Molecular Cage With Potential to Deliver Vaccines Developed At UCLA

Posted by Laura Braden on Tue, Jan 06, 2015

Biochemists at the University of California, Los Angeles recently developed the largest molecular "cage" ever created. This "cage", a cube-like structure, was constructed from 24 copies of a single protein that has the ability to self-assemble into a cage. This newly created cage could potentially lead to new ways of delivering vaccines to infected cells. 

Read More

Tags: CA, University of California Los Angeles, Southwest, 2015, LAVS, UCLA, Biotechnology Vendor Showcase

Los Angeles Life Scientists Correlate Autophagy With Anti-Aging

Posted by Sam Asher on Thu, Sep 11, 2014

This June, we saw that Ann Arbor researchers were adjusting the process of cell autophagy in order to fight cancerous tumors. (You can read our article on the subject here.) This September, life scientists at the University of California, Los Angeles have found that tapping into autophagy may prevent the inevitable: that is, the aging of the human body.

Read More

Tags: 2014, CA, University of California Los Angeles, California, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase

UCLA Receives more $ with $15M Life Science Grant

Posted by Jennifer Nieuwkerk on Mon, Aug 11, 2014

Part of a new $37.5 million life science grant from the Defense Advanced Research Projects Agency has been made available to researchers at the University of California, Los Angeles. The research funding will be shared with fellow science researchers at the University of Pennsylvania to build and test wireless implantable devices that can detect memory deficits caused by injury and try to restore normal function. The purpose of these devices is to help improve brain function for service members, veterans and others after traumatic brain injury or disease.

Read More

Tags: 2014, CA, University of California Los Angeles, new research funding, California, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, new research grant

$7.2M in Life Science Funding for Genetic Disease Study Awarded to UCLA

Posted by Jennifer Nieuwkerk on Mon, Jul 28, 2014

The National Institutes of Health has awarded the University of California, Los Angeles a $7.2 million life science grant to study genetic diseases and develop ways to diagnose rare genetic disorders. UCLA is the only university on the West Coast and one of only three in the United States with a laboratory that can carry out genomic sequence directly usable for patient care, making it the ideal university to receive this life science grant.

Read More

Tags: 2014, CA, new research funding, Southwest, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, life science grant, UC Los Angeles

Life Science Grant Worth $5.1M Awarded to UCLA Researcher

Posted by Jennifer Nieuwkerk on Mon, Jun 09, 2014

A research scientist at the University of California, Los Angeles recently received a $5.1 million life science grant for stem cell research from the California Institute of Regenerative Medicine. California’s state stem cell agency awarded the new research funding to UCLA’s Dr. John Chute so that he may further his investigations into creating new stem cell therapies in the medical field.

Read More

Tags: 2014, CA, University of California Los Angeles, new research funding, California, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, life science grant

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!